PL-3994 is under investigation in clinical trial NCT01304628 (Cross-Over Study of Subcutaneous Study Drug for the Treatment of Patients With Mild to Moderate Asthma).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.